Left atrial appendage occlusion debate revisited.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation

• Publication date

  2015-02-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.114.008840PMID 25712058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

  2014cited by this paper
• Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

  2014cited by this paper
• Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

  2013cited by this paper
• The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies.

  2013cited by this paper
• Death from pulmonary artery erosion complicating implantation of percutaneous left atrial appendage occlusion device.

  2013cited by this paper
• Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial

  2013cited by this paper
• Edoxaban versus warfarin in patients with atrial fibrillation.

  2013cited by this paper
• Apixaban versus Warfarin in Patients with Atrial Fibrillation

  2012cited by this paper
• Persistence with therapy among patients treated with warfarin for atrial fibrillation.

  2012cited by this paper
• Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

  2012cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Apixaban versus warfarin in patients with atrial fibrillation.

  2011cited by this paper
• Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.

  2011cited by this paper
• Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Medication Adherence in Cardiovascular Disease

  2010cited by this paper
• Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

  2009cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Medication Adherence: Its Importance in Cardiovascular Outcomes

  2009cited by this paper
• Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin

  2009cited by this paper
• Left Atrial Appendage Occlusion Eliminates the Need for Warfarin

  2009cited by this paper
• Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

  2009cited by this paper
• Does point‐of‐care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial

  2009cited by this paper
• Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.

  2008cited by this paper
• Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

  2008cited by this paper
• Endothelial dysfunction and pathophysiological correlates in atrial fibrillation

  2008cited by this paper
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)

  2008cited by this paper
• Occluding the left atrial appendage: anatomical considerations

  2007cited by this paper
• Malpositioning of a left atrial appendage occlusion device? A case with implications for percutaneous transcatheter left atrial appendage occlusion device therapy.

  2007cited by this paper
• Adherence to Warfarin Assessed by Electronic Pill Caps, Clinician Assessment, and Patient Reports: Results from the IN-RANGE Study

  2007cited by this paper
• Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

  2007cited by this paper
• Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation

  2006cited by this paper
• Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry.

  2006cited by this paper
• Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.

  2006cited by this paper
• Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.

  2006cited by this paper
• Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.

  2005cited by this paper
• Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost

  2005cited by this paper
• Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

  2005cited by this paper
• National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.

  2004cited by this paper
• Population rates of hospitalization for atrial fibrillation/flutter in Canada.

  2004cited by this paper
• Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study.

  2003cited by this paper
• Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)

  2002cited by this paper
• Helping patients follow prescribed treatment: clinical applications.

  2002cited by this paper
• Adherence with statin therapy in elderly patients with and without acute coronary syndromes.

  2002cited by this paper
• Thromboembolus from a ligated left atrial appendage.

  2001cited by this paper
• Adequacy of Anticoagulation in Patients with Atrial Fibrillation Coming to a Hospital

  2000cited by this paper
• Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study.

  2000cited by this paper
• Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists.

  1999cited by this paper
• Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

  1999cited by this paper
• Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.

  1999cited by this paper
• Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.

  1999cited by this paper
• Recent national patterns of warfarin use in atrial fibrillation.

  1998cited by this paper
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.

  1998cited by this paper
• Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

  1996cited by this paper
• Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation.

  1995influential reference
• Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation.

  1995cited by this paper
• Is this patient taking the treatment as prescribed

  1993cited by this paper
• The rational clinical examination. Is this patient taking the treatment as prescribed?

  1993cited by this paper
• Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli.

  1949cited by this paper

• Peri- and Post-procedural Anticoagulation with Left Atrial Appendage Occlusion Devices.

  2023cites this paper
• Left atrial appendage exclusion is effective in reducing postoperative stroke after mitral valve replacement

  2020cites this paper
• Incidence and characteristics of left atrial appendage stumps after device-enabled epicardial closure.

  2019cites this paper
• Ligating the left atrial appendage in atrial fibrillation: What additional evidence do surgeons need?

  2019cites this paper
• Multimodality Imaging for Best Dealing With Patients in Atrial Arrhythmias.

  2019cites this paper
• Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery

  2018cites this paper
• Cierre percutáneo de la auriculilla izquierda en el manejo de la fibrilación auricular

  2018cites this paper
• Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?

  2018cites this paper
• Left Atrial Appendage Segmentation Using Fully Convolutional Neural Networks and Modified Three-Dimensional Conditional Random Fields

  2018cites this paper
• Pneumatic Burst Pressures After Inverted Closure of the Left Atrial Appendage: An Ex Vivo Model.

  2017cites this paper
• Seguridad y eficacia a corto plazo del cierre de orejuela izquierda con dispositivo WATCHMAN® en fibrilación auricular no valvular en pacientes con alto riesgo de sangrado

  2017cites this paper
• Delayed left atrial appendage contrast filling in computed tomograms after percutaneous left atrial appendage occlusion.

  2017cites this paper
• SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion.

  2016cites this paper
• SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion

  2016cites this paper
• SCAI/ACC/HRS Institutional and Operator Requirements for Left Atrial Appendage Occlusion.

  2016cites this paper
• Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.

  2016cites this paper
• Left Atrial Appendage Closure for Stroke Prevention is Safe and Effective in Selected Patients with Atrial Fibrillation

  2016cites this paper
• Left atrial appendage closure versus oral anticoagulation for preventing stroke in people with atrial fibrillation

  2016cites this paper
• SCAI/ACC/HRS Institutional and Operator Requirements for Left Atrial Appendage Occlusion

  2016cites this paper
• atrial appendage occlusion(左心耳閉鎖デバイス)(用語解説)

  2015influential citation
• Letter by Salzberg and Emmert Regarding Article, "Left Atrial Appendage Occlusion Debate Revisited".

  2015influential citation
• Atrial Fibrillation Pathophysiology and Prognosis: Insights From Cardiovascular Imaging

  2015cites this paper
• Response to Letter Regarding Article, "Left Atrial Appendage Occlusion Debate Revisited".

  2015cites this paper